BACKGROUND: Increased serum leptin concentration has been linked to increased ventilation in patients with mild heart failure (HF). However, in animal models the absence of leptin has also been associated with increased ventilation. This study evaluated the relationship of circulating leptin concentration with exercise ventilation in HF patients. METHODS AND RESULTS: Fifty-eight consecutive ambulatory HF patients were stratified by quintiles of leptin concentration, with a lowest quintile of mean leptin concentration of 1.8 ± 8.9 ng/mL and a highest of 33.3 ± 30.3 ng/mL. Peak exercise ventilatory efficiency (VE/VCO2) was significantly elevated in the lowest (46 ± 6 vs 34 ± 4; P < .01) as well as in the highest (38 ± 8 vs 34 ± 4; P < .05) leptin concentration quintiles compared with the reference middle quintile. Multiple regression analysis adjusted for confounders such as age, sex, and body mass index showed leptin concentration to be independently inversely correlated to VE/VCO2 in the low-to-normal quintiles (β = -0.64; P < .01), positively in the normal-to-high quintiles (β = 0.52; P = .02), and positively correlated to PETCO2 in the low-to-normal quintiles (β = 0.59; P = .01) and inversely in the normal-to-high quintiles (β = -0.53; P = .02). CONCLUSIONS: In HF patients, both high and low leptin concentrations are associated with increased VE/VCO2 and decreased PETCO2 with a nonlinear U-shaped relationship, suggesting that either leptin deficiency or leptin resistance may modulate ventilatory control in HF patients.

International Clinical Research Center Department of Anesthesiology and Intensive Care St Anna's University Hospital Brno Czech Republic; Division of Cardiovascular Diseases Mayo Clinic Rochester Minnesota

See more in PubMed

Woods PR, Olson TP, Frantz RP, Johnson BD. Causes of breathing inefficiency during exercise in heart failure. J Card Fail. 2010 Oct;16(10):835–42. PubMed PMC

Arena R, Myers J, Aslam SS, Varughese EB, Peberdy MA. Peak VO2 and VE/VCO2 slope in patients with heart failure: a prognostic comparison. Am Heart J. 2004 Feb;147(2):354–60. PubMed

Osborn O, Sanchez-Alavez M, Brownell SE, Ross B, Klaus J, Dubins J, et al. Metabolic characterization of a mouse deficient in all known leptin receptor isoforms. Cell Mol Neurobiol. 2010 Jan;30(1):23–33. PubMed PMC

Karmazyn M, Purdham DM, Rajapurohitam V, Zeidan A. Leptin as a cardiac hypertrophic factor: a potential target for therapeutics. Trends Cardiovasc Med. 2007 Aug;17(6):206–11. PubMed

Malli F, Papaioannou AI, Gourgoulianis KI, Daniil Z. The role of leptin in the respiratory system: an overview. Respir Res. 2010 Oct 31;11(1):152. PubMed PMC

Wolk R, Johnson BD, Somers VK. Leptin and the ventilatory response to exercise in heart failure. J Am Coll Cardiol. 2003;42(9):1644–9. Listopad. PubMed

Tankersley CG, O’Donnell C, Daood MJ, Watchko JF, Mitzner W, Schwartz A, et al. Leptin attenuates respiratory complications associated with the obese phenotype. J Appl Physiol Bethesda Md 1985. 1998 Dec;85(6):2261–9. PubMed

Tankersley C, Kleeberger S, Russ B, Schwartz A, Smith P. Modified Control of Breathing in Genetically Obese (ob/Ob) Mice. J Appl Physiol. 1996 Aug 1;81(2):716–23. PubMed

Martin SS, Qasim A, Reilly MP. Leptin ResistanceA Possible Interface of Inflammation and Metabolism in Obesity-Related Cardiovascular Disease. J Am Coll Cardiol. 2008 Oct 7;52(15):1201–10. PubMed PMC

Schwartz MW, Prigeon RL, Kahn SE, Nicolson M, Moore J, Morawiecki A, et al. Evidence That Plasma Leptin and Insulin Levels are Associated With Body Adiposity Via Different Mechanisms. Dia Care. 1997 Sep 1;20(9):1476–81. PubMed

Campo A, Frühbeck G, Zulueta JJ, Iriarte J, Seijo LM, Alcaide AB, et al. Hyperleptinaemia, respiratory drive and hypercapnic response in obese patients. Eur Respir J Off J Eur Soc Clin Respir Physiol. 2007 Aug;30(2):223–31. PubMed

Jessup M, Abraham WT, Casey DE, Feldman AM, Francis GS, Ganiats TG, et al. 2009 Focused Update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in AdultsA Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the International Society for Heart and Lung Transplantation. J Am Coll Cardiol. 2009;53(15):1343–82. Duben. PubMed

Wolk R, Deb A, Caplice NM, Somers VK. Leptin receptor and functional effects of leptin in human endothelial progenitor cells. Atherosclerosis. 2005 Nov;183(1):131–9. PubMed

Clerico A, Giannoni A, Vittorini S, Emdin M. The paradox of low BNP levels in obesity. Heart Fail Rev. 2012 Jan;17(1):81–96. PubMed

O’donnell CP, Schaub CD, Haines AS, Berkowitz DE, Tankersley CG, Schwartz AR, et al. Leptin prevents respiratory depression in obesity. Am J Respir Crit Care Med. 1999 May;159(5 Pt 1):1477–84. PubMed

Shimura R, Tatsumi K, Nakamura A, Kasahara Y, Tanabe N, Takiguchi Y, et al. Fat accumulation, leptin, and hypercapnia in obstructive sleep apnea-hypopnea syndrome. Chest. 2005 Feb;127(2):543–9. PubMed

Wolk R, Somers VK. Leptin and Vascular Function: Friend or Foe? Eur Heart J. 2006 Oct 1;27(19):2263–5. PubMed

Couillard C, Mauriège P, Prud’homme D, Nadeau A, Tremblay A, Bouchard C, et al. Plasma leptin concentrations: gender differences and associations with metabolic risk factors for cardiovascular disease. Diabetologia. 1997 Oct;40(10):1178–84. PubMed

Aitken ML, Franklin JL, Pierson DJ, Schoene RB. Influence of body size and gender on control of ventilation. J Appl Physiol. 1986 Jun 1;60(6):1894–9. PubMed

Guazzi M, Arena R, Myers J. Comparison of the prognostic value of cardiopulmonary exercise testing between male and female patients with heart failure. Int J Cardiol. 2006 Nov 18;113(3):395–400. PubMed

Fain JN, Kanu A, Bahouth SW, Cowan GSM, Lloyd Hiler M. Inhibition of leptin release by atrial natriuretic peptide (ANP) in human adipocytes. Biochem Pharmacol. 2003 Jun 1;65(11):1883–8. PubMed

Yuan K, Yu J, Shah A, Gao S, Kim SY, Kim SZ, et al. Leptin reduces plasma ANP level via nitric oxide-dependent mechanism. Am J Physiol Regul Integr Comp Physiol. 2010 Apr;298(4):R1007–1016. PubMed

Polak J, Kotrc M, Wedellova Z, Jabor A, Malek I, Kautzner J, et al. Lipolytic effects of B-type natriuretic peptide 1–32 in adipose tissue of heart failure patients compared with healthy controls. J Am Coll Cardiol. 2011 Sep 6;58(11):1119–25. PubMed

Costello-Boerrigter LC, Burnett JC. A new role for the natriuretic peptides: Metabolic regulators of the adipocyte. J Am Coll Cardiol. 2009 Jun 2;53(22):2078–9. PubMed PMC

Tisdale MJ. Mechanisms of Cancer Cachexia. Physiol Rev. 2009 Apr 1;89(2):381–410. PubMed

Ruhl CE, Harris TB, Ding J, Goodpaster BH, Kanaya AM, Kritchevsky SB, et al. Body mass index and serum leptin concentration independently estimate percentage body fat in older adults. Am J Clin Nutr. 2007 Apr 1;85(4):1121–6. PubMed

Horwich TB, Hamilton MA, Fonarow GC. B-Type Natriuretic Peptide Levels in Obese Patients With Advanced Heart Failure. J Am Coll Cardiol. 2006;47(1):85–90. Leden. PubMed

Shah NR, Braverman ER. Measuring Adiposity in Patients: The Utility of Body Mass Index (BMI), Percent Body Fat, and Leptin. PLoS ONE. 2012 Apr 2;7(4):e33308. PubMed PMC